Treated patients were compared with historic controls consisting of patients with classical or multifocal CSCR previously followed up at our institution.Results: Mean visual acuity in the group treated with aspirin started to improve after the first week of therapy and continued to improve throughout the following 3 months. However, one study using low-dose aspirin reported lower recurrence of the disease, ... DME, and macular edema secondary to radiation retinopathy. Type A behavior and central serous chorioretinopathy. Michael Colucciello, MD Central serous chorioretinopathy (also referred to as central serous retinopathy, but more appropriately termed a chorioretinopathy) is a condition characterized by a serous macular detachment due to a focal disruption in the outer blood-retinal barrier. There can be partial or complete loss of vision. From editorial acceptance to publication. •  software development by maffey.com open access to scientific and medical research. The retina is a thin, sensitive layer of tissue in the back of the eye. Retinopathy means that disease has damaged the retina. 1974;77(2):158-160. Therefore, it is important to discuss with your eye doctor regarding the food, which might have serious effect on blood thinning and thereby may enhance CSR. For many people, the condition clears without treatment. The retina is the part inside the eye that senses light. retinopathy, central serous retinopathy, and central serous pigment epitheliopathy.2,3 CSCR usually affects middle-aged men between the ages of twenty and fifty years.4–6 It has also been associ-ated with type A personality, or those who are experienc- Central serous retinopathy (CSR) or central serous chorioretinopathy (CSCR) affects the central area of your retina known as the macula. conducted a prospective trial in which patients treated with six months of 100 mg aspirin … When these vessels become excessively leaky, fluid builds up in the choroid and some of that fluid can break through the barrier of the retinal pigment epithelium. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms. Type A behavior and central serous chorioretinopathy. Treated patients were compared with historic controls consisting of patients with classical or multifocal CSCR previously followed up at our institution. Central serous retinopathy and pregnancy. This site is owned and operated by Informa PLC ( “Informa”) whose registered office is 5 Howick Place, London SW1P 1WG. 1986;84:799-845. Central serous retinopathy is an eye condition in which fluid builds up behind the retina and affects your vision. retinopathy, central serous retinopathy, and central serous pigment epitheliopathy.2,3 CSCR usually affects middle-aged men between the ages of twenty and fifty years.4–6 It has also been associ-ated with type A personality, or those who are experienc- this site will not function whilst javascript is disabled. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. Number 3099067. Central Serous Retinopathy (CSR) causes blurriness of central vision for about a 3 month period of time. There are several theories on the pathogenesis of CSC: One emphasizes that This study aims to report 3-year clinical outcomes of patients treated with eplerenone for chronic CSCR. Central serous chorioretinopathy (CSC) is a disease in which serous retinal detachment is seen, often associated with detachment of the retinal pigment epithelium (RPE) [ 1 – 10 ]. The main symptoms of central serous retinopathy are blurry vision in the affected eye, as well as distorted vision and/or seeing things smaller than they really are. Thus, novel therapies to combat this frustrating disorder are needed. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Central serous retinopathy is caused by excessively leaky blood vessels in the choroid which is the layer of blood vessels under the retina.